Jagsonpal Pharmaceuticals Market Cap

Jagsonpal Pharmaceuticals has a market cap or net worth of 12.89 billion as of April 17, 2026. Its market cap has decreased by -9.23% in one year.

Market Cap

12.89B

Enterprise Value

11.38B

Revenue

2.82B

Ranking

n/a

PE Ratio

31.64

Stock Price

191.94

Market Cap Chart

Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 12.89B, a decrease of -26.91%. That is a compound annual growth rate of -1.19%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2026	12.89B	0.19%
Dec 31, 2025	12.86B	-20.68%
Dec 31, 2024	16.22B	58.61%
Dec 29, 2023	10.22B	4.69%
Dec 30, 2022	9.77B	108.36%
Dec 31, 2021	4.69B	150.03%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Innova Captab	41.62B
RPG Life Sciences	31.42B
Orchid Pharma	28.69B
Solara Active Pharma Sciences	23.68B
Indoco Remedies	20.04B
Windlas Biotech	18.35B
Beta Drugs	14.00B
Sakar Healthcare	13.13B

Market Cap Rankings